SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCerillion Regulatory News (CER)

Share Price Information for Cerillion (CER)

Share Price is delayed by 15 minutes
Get Live Data
1,240.00    30.00 (2.46%)
Bid:
1,230.00
Ask:
1,250.00
Spread: 20.00 (1.626%)
Market Cap: £369.26m
CER Live PriceLast checked at - London Stock Exchange

Intraday Cerillion Share Chart

Replacement - Purchase, Options Exercise, Dividend

19 Nov 2024 14:07

RNS Number : 8395M
Cerillion PLC
19 November 2024
 

The following amendment has been made to the 'Share purchase for Long-Term Incentive Plan, exercise of options under LTIP, PDMR shareholdings and dividend declaration' announcement released on 19 November 2024 at 07:00 a.m. under RNS No 7006M. The final dividend amount under the 'Dividend Declaration - timing update' header has been corrected to 9.2p from 8.0p. All other details remain unchanged. The full amended text is shown below.

 

Cerillion plc

("Cerillion" or the "Company")

 

Share purchase for Long-Term Incentive Plan, exercise of options under LTIP, PDMR shareholdings and dividend declaration

 

Cerillion, the billing, charging and customer relationship management software solutions provider, announces that on 18 November, the Company purchased into treasury 32,500 shares of 0.5 pence each in the Company ("Ordinary Shares") at an average price of 1910 pence per Ordinary Share.

 

The 32,500 Ordinary Shares were immediately issued from treasury to certain members of senior management (set out below) who have exercised their rights pursuant to the Company's Long-Term Incentive Plan ("LTIP"), details of which were announced on 19 September 2017. These options, that are exercisable at the nominal value of the Ordinary Shares, were subject to the achievement of targets for compound annual growth in the share price of the Company over the original three-year vesting period.

 

PDMR

Role

LTIPs exercised

Alistair Carwardine

SVP Asia Pacific

5,000

Arif Bhavnagarwalla

Head of Operations, India

5,000

Mark Nicholls

Chief Operating Officer

7,500

Amit McCann

Account Development Director

5,000

Andrew Smith

Marketing Director

5,000

Richard Doughty

Business Development Director

5,000

 

The information below is set out in accordance with the requirements of the Market Abuse Regulation (EU) 596/2014 (which forms part of UK domestic law pursuant to the European Union (Withdrawal) Act 2018, as amended), provides further details of the transaction EU Market Abuse Regulation, provides further detail on the sales.

 

Treasury Shares

Following the transfer, the Company holds no shares in Treasury.

 

Total voting rights

Following the exercise of LTIPs, the total number of Ordinary Shares in issue, for the purposes of the Financial Conduct Authority's Disclosure and Transparency Rules, remains unchanged at 29,535,614 with each share carrying the right to one vote.

The above figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Disclosure and Transparency Rules.

 

Dividend Declaration - timing update

 

Further to the Company's final results for the year ended 30 September 2024, as announced on 18 November 2024, the Company provides an update on the proposed dividend timetable. The final dividend of 9.2p* per share, which is subject to shareholder approval at the Company's Annual General Meeting to be held on 13 February 2025, will be payable on 20 February 2025 to those shareholders on the Company's register as at the close of business on the record date of 17 January. The ex-dividend date is 16 January 2025.

 

 

Enquiries:

Cerillion plc

c/o KTZ Communications

Louis Hall, CEO

T: 020 3178 6378

Andrew Dickson, CFO

Panmure Liberum Limited (Nomad and Joint Broker)

T: 020 3100 2000

Bidhi Bhoma, Edward Mansfield, Freddie Wooding

Singer Capital Markets (Joint Broker)

T: 020 7496 3000

Rick Thompson, James Fischer

KTZ Communications

T: 020 3178 6378

Katie Tzouliadis, Robert Morton

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

 

Name

Alistair Carwardine

Arif Bhavnagarwalla

Mark Nicholls

Amit McCann

Andrew Smith

Richard Doughty

2

Reason for the notification

a)

 

Position/status

SVP Asia Pacific

Head of Operations, India

Chief Operating Officer

Account Development Director

Marketing Director

Business Development Director

b)

 

Initial notification /Amendment

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

 

Name

Cerillion PLC

b)

 

LEI

213800ISIZMUC3P46850

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted  

a)

 

Description of the financial instrument, type of instrument

  Identification code

 

 Ordinary shares of GBP 0.005 each

GB00BYYX6C66

b)

 

Nature of the transaction

 

Exercise of options into Ordinary Shares under the LTIP

 

c)

 

Price(s) and volume(s)

 

 

  Price(s)

 

Volume(s)

0.5 pence

5,000

0.5 pence

5,000

0.5 pence

7,500

0.5 pence

5,000

0.5 pence

5,000

0.5 pence

5,000

 

d)

 

Aggregated information

- Aggregated volume

 - Price

 

32,500 Ordinary Shares

0.5 pence

 

e)

 

Date of the transaction

18 November 2024

f)

 

Place of the transaction

 

Outside a trading venue

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFFSFLUELSESF
Date   Source Headline
30th Nov 20226:29 pmRNSPDMR and PCA shareholding
30th Nov 202211:18 amRNSHolding(s) in Company
28th Nov 20227:00 amRNSFinal Results
23rd Nov 20227:00 amRNSNotice of Results and Investor Presentation
2nd Nov 20225:49 pmRNSHolding(s) in Company
2nd Nov 202212:40 pmRNSHolding(s) in Company
26th Oct 20227:00 amRNSRelease of latest version of flagship product set
24th Oct 20227:00 amRNSTrading Update
6th Oct 20227:00 amRNSAppointment of Joint Broker
25th Aug 20223:48 pmRNSGrant of Options
8th Aug 20223:08 pmRNSHolding(s) in Company
28th Jul 20224:35 pmRNSPrice Monitoring Extension
19th Jul 20227:00 amRNSHolding(s) in Company
6th Jul 20227:00 amRNSMajor Contract Win
13th May 20227:33 amRNSDirector Share Purchase
9th May 20227:00 amRNSInterim Results Presentation
9th May 20227:00 amRNSInterim Results
25th Apr 202210:13 amRNSHolding(s) in Company
19th Apr 20227:00 amRNSH1 2022 Trading Update
6th Apr 20227:00 amRNSCerillion Client MVN-X Reaches Million Subscribers
7th Mar 20227:00 amRNSWins Prestigious Megabuyte Performance Award
2nd Mar 20227:00 amRNSExercise of Options, PDMR Shareholding & TVR
21st Feb 20223:08 pmRNSHolding(s) in Company
21st Feb 20227:00 amRNSShare purchase for Employee Share Option Scheme
15th Feb 20227:00 amRNSRecognised in Two Gartner Market Guide Reports
4th Feb 202211:37 amRNSResult of AGM
31st Jan 20227:00 amRNSConfirmation of Board Appointment
27th Jan 20222:25 pmRNSHolding(s) in Company
24th Jan 20222:05 pmRNSSecond Price Monitoring Extn
24th Jan 20222:00 pmRNSPrice Monitoring Extension
10th Jan 20227:00 amRNSCompletion of Implementation for Norlys
14th Dec 20217:00 amRNSBoard Retirement and Proposed Appointment
26th Nov 20218:37 amRNSPDMR and PCA Shareholding
22nd Nov 20217:00 amRNSFinal Results
16th Nov 20212:42 pmRNSHolding(s) in Company
2nd Nov 20217:00 amRNSRelease of Cerillion 21.2
4th Oct 20217:02 amRNSTrading Update
28th Sep 20217:00 amRNSContracts worth £4.2m with OpenNet
23rd Sep 20216:15 pmRNSHolding(s) in Company
9th Sep 20217:00 amRNSOpening of Bulgaria office
8th Sep 20217:00 amRNSInvestor Presentation
22nd Jul 20214:24 pmRNSHolding(s) in Company
13th Jul 202111:03 amRNSHolding(s) in Company
6th Jul 202111:30 amRNSDirector/PDMR Shareholding
22nd Jun 20217:00 amRNSGrant of Options
18th Jun 20217:00 amRNSEmployee Share Option Scheme
10th Jun 202111:35 amRNSDirector/PDMR shareholding
27th May 20216:03 pmRNSReplacement: Director/PDMR Shareholding
27th May 20213:50 pmRNSDirector/PDMR Shareholding
24th May 20214:59 pmRNSExercise of Options and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.